KPIs & Operating Metrics(New)
Growth Metrics

Tenet Healthcare (THC) Cash & Equivalents (2016 - 2026)

Tenet Healthcare (THC) has disclosed Cash & Equivalents for 18 consecutive years, with $3.0 billion as the latest value for Q1 2026.

  • For Q1 2026, Cash & Equivalents fell 1.07% year-over-year to $3.0 billion; the TTM value through Mar 2026 reached $3.0 billion, down 1.07%, while the annual FY2025 figure was $2.9 billion, 4.5% down from the prior year.
  • Cash & Equivalents hit $3.0 billion in Q1 2026 for Tenet Healthcare, up from $2.9 billion in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $4.1 billion in Q3 2024 and bottomed at $766.0 million in Q1 2023.
  • Average Cash & Equivalents over 5 years is $2.1 billion, with a median of $2.5 billion recorded in 2024.
  • Year-over-year, Cash & Equivalents plummeted 63.71% in 2022 and then soared 288.43% in 2024.
  • Tenet Healthcare's Cash & Equivalents stood at $858.0 million in 2022, then surged by 43.12% to $1.2 billion in 2023, then soared by 145.85% to $3.0 billion in 2024, then fell by 4.5% to $2.9 billion in 2025, then grew by 2.91% to $3.0 billion in 2026.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $3.0 billion, $2.9 billion, and $3.0 billion for Q1 2026, Q4 2025, and Q3 2025 respectively.